1. Zeerak S, Godse K, Kumar S. Awareness of Family Physicians Towards Antihistamines. Indian J Dermatol. 2019; 64(2): 112–114
2. Church MK, Church DS. Pharmacology of Antihistamines. Indian J Dermatol. 2013; 58(3): 219-224.
3. Casale TB, Blaiss MS, Gelfand E, et al. First Do No Harm: Managing Antihistamine Impairment in Patients with Allergic Rhinitis. J Allergy Clin Immunol. 2003; 111(5): S835-842.
4. Randall KL, Hawkins CA. Antihistamines and Allergy. Aust Prescr. 2018;41(2):41-45
5. Church MK, Maurer M, Simons FE, Bindslev-Jensen C, Cauwenberge PV, Bousquet J, et al. Risk of First-generation H(1)-antihistamines: a GA(2)LEN position paper. Allergy. 2010;65(4):459–66
6. Scharman EJ, Erdman AR, Wax PM, Chyka PA, Caravati EM, Nelson LS, et al. Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2006;44(3):205–23.
7. Schlit AF, Delaunois A, Colomar A, Claudio B, Cariolato L, Boev R, et al. Risk of QT Prolongation and Torsade de Pointes Associated with Exposure to Hydroxyzine: re-evaluation of an established drug. Pharmacol Res Perspect. 2017;5(3):e00309.
8. Vigne J, Alexandre J, Fobe F, Milliez P, Loilier M, Fedrizzi S, Coquerel A. QT prolongation induced by hydroxyzine: a pharmacovigilance case report. Eur J Clin Pharmacol. 2015;71(3):379–81
9. Shamizadeh S, Brockow K, Ring J. Rupatadine: Efficacy and Safety of A Nonsedating Antihistamine with PAF-Antagonist Effects. Allergo J Int. 2014; 23(3): 87-95.
10. García-Gea C, Martínez J, Ballester M, Gich I, Valiente R, Antonijoan R. Psychomotor and Subjective Effects of Bilastine, Hydroxyzine, and Cetirizine, In Combination with Alcohol: A Randomized, Double-Blind, Crossover, and Positive-Controlled and Placebo-Controlled Phase I clinical trials. Human Psychopharmacology. 2014; 29(2): 120-32.
11. Zuberbier T, Aberer W, Asero R, Latiff AH, Baker D, Ballmer-Weber B. The EAACI/GA(2)LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2018; 73(5): 1393-1414.
12. Klimek L, Bachert C, Pfaar O, Becker S, Bieber T, Brehler R, et al. ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergol Select. 2019; 3(1): 22–50.